Navigation Links
KJT Group Hires Director of Health Outcomes
Date:7/9/2013

HONEOYE FALLS, N.Y., July 8, 2013 /PRNewswire/ -- KJT Group, Inc. is pleased to announce the hiring of Arun Changolkar, PhD, MBA as the Director of Health Outcomes Research to its expanding life sciences research and consulting organization.

Dr. Changolkar, of Philadelphia, brings extensive academic and professional experience in health economics and outcomes research. His experience includes leadership roles in the pharmaceutical and clinical research industries. With expertise in epidemiology and statistics his project experience spans both U.S. and global healthcare in oncology, vaccines, and autoimmune disease. 

He joins KJT Group after serving in various industry positions including Director of Global Health Outcomes at Stiefel and Manager of Health Outcomes and Analytics at GlaxoSmithKline. His experience includes the design and execution of HEOR studies to support multiple global country specific successful reimbursement submissions, supporting clinical trials, and various other post-marketing observational studies to generate clinical evidence.  He also participated in and contributed to strategic pricing, global value dossier synthesis, and core value development for various pharmaceutical products. Changolkar's accomplishments include numerous abstracts in international and national scientific meetings and 11 publications in scientific journals. 

"Arun brings a very nice mix of skills and experience to KJT Group's growing Health Outcomes Practice. Having worked on both the client and vendor sides he brings strong analytic skills as well as a clear understanding of the underlying business issues that our customers face," said Kenneth Tomaszewski, PhD, MS, Founder and CEO of KJT Group.

Following the completion of his PhD, Changolkar received post-doctoral training as an Anticancer Drug Discovery Researcher at Harvard Medical School and an Epigenetics Researcher at the University of Pennsylvania in Philadelphia.

As the Director of Health Outcomes Research at KJT Group, Changolkar will work closely with KJT Group researchers and oversee the design and conduct of KJT Group's health economics and outcomes research studies.

About KJT Group: KJT Group (www.kjtgroup.com) is a full service life sciences market research and insight consultancy firm. Established in 2007, KJT Group employs nearly 50 full-time staff in New York, Pennsylvania, Texas, South Carolina and The Netherlands. KJT Group is a member of the National Council on Public Polls (NCPP), Council of American Survey Research Organizations (CASRO) and the European Society Opinion and Marketing Research (ESOMAR).


'/>"/>
SOURCE KJT Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
2. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
3. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
4. Cellular Biomedicine Group Announces Appointment of Corporate Controller
5. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
6. The JTB Law Group Continues to Innovate with its New Video Information Series and Vivid Legal Cartoons
7. The Hemostemix Group of Companies Provides Corporate Strategy Update
8. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
9. YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group
10. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
11. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):